(Q36614950)

15 August 2017

1 reference

title

FK 506: an immunosuppressant for the 1990s? (English)

1 reference

15 August 2017

1 reference

A. M. Macleod

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702172

2 November 2022

A. W. Thomson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702172

2 November 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

15 August 2017

5 January 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1702172

full work available at URL

2 November 2022

https://api.elsevier.com/content/article/PII:0140673691933416?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

https://api.elsevier.com/content/article/PII:0140673691933416?httpAccept=text/plain

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

2 November 2022

1 reference

15 August 2017

volume

337

1 reference

15 August 2017

issue

8732

1 reference

15 August 2017

page(s)

25-27

1 reference

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

15 August 2017

cites work

4

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

The Influence of FK-506 and Low-Concentration Ciclosporin on Human Lymphocyte Activation Antigen Expression and Blastogenesis: a Flow Cytometric Analysis

2 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506

2 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

2 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase

2 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

FK506--its influence on anti-class 1 MHC alloantibody responses to blood transfusions

2 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

FK 506 for liver, kidney, and pancreas transplantation

2 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine

2 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy

2 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats

2 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

Studies of the effects of FK506 on renal allografting in the beagle dog.

2 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

Augmentation of rat liver regeneration by FK 506 compared with cyclosporin

2 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

Prolongation of cardiac xenograft survival in rats treated with 15-deoxyspergualin alone and in combination with FK506

2 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

Prevention of spontaneous diabetes in BB rats with FK 506

2 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

Immunosuppressive effect of FK506 on collagen-induced arthritis in rats

2 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosus

2 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine

2 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

Observations about FK-506 in primates

2 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

A highly sensitive method to assay FK-506 levels in plasma

2 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement

2 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood.

2 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)93341-6

2 November 2022

Identifiers

1 reference

15 August 2017

1 reference